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I. INTRODUCTION
Tooth eruption is a precisely timed, complex
process, which requires localized bone resorption
to form an eruption pathway (Marks, 1981) and
a functioning dental follicle to regulate local
bone metabolism (Marks and Cahill, 1987).
Colony-stimulating factor (CSF)-1 is considered
to play a role in the complex process of tooth
eruption. It has been proposed that CSF-1 en-
hances local alveolar bone resorption by increas-
ing the number of mononuclear cells in the
dental follicle and osteoclasts on adjacent alveo-
lar bone surfaces (Cielinski et al., 1995; Que and
Wise, 1997). Dental follicle cells transcribe and
translate CSF-1 (Wise and Lin, 1994; Wise et
al., 1995) and express receptors for CSF-1 (Wise
et al., 1997). The peak gene expression of CSF-1
in the follicle of the rat lower first molar, is at day
3 postnatally (Wise et al., 1995), coincidental
with the timing for the maximum influx of
monocytes into the follicle (Wise and Fan, 1989;
Cielinski et al., 1994).
The toothless (tl/tl) rat is an osteopetrotic
animal in which osteoclast, macrophage, and
mononuclear cell numbers are reduced (Seifert,
1996; Seifert et al., 1988). In this osteopetrotic
animal, teeth form but fail to erupt, and remain
embedded within their bony crypts (Iizuka et al.,
1992). The bone defect in this mutation is not
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cured by bone marrow transplantation (Marks,
1977) but is improved following treatment with
CSF-1 (Iizuka et al., 1992; Marks et al., 1993).
CSF-1 treatment of tl/tl rats from birth pro-
motes eruption of incisors and molars, which is
delayed compared with normal littermates (Iizuka
et al., 1992).
CSF-1 affects the proliferation, differentia-
tion, and survival of mononuclear phagocyte
lineage cells (Stanley et al., 1983) and promotes
the formation of osteoclasts from hematopoietic
stem cells (Antonioli-Corboz et al., 1992; Tanaka
et al., 1993). Treatment of tl/tl mutants with
CSF-1 increases osteoclasts, macrophages, and
bone resorption and permits tooth eruption (Iizuka
et al., 1992, Marks et al., 1992, 1993). In the
tibia, we have shown that CSF-1 treatment
upregulates the immunoreactivity of bone mar-
row mononuclear cells (BMMC) to growth hor-
mone receptor (GHr), insulin-like growth factor
(IGF)-I, and IGF-I receptor (IGF-Ir), and in-
creases the number of tartrate-resistant acid phos-
phatase (TRAP)-positive osteoclasts (Symons et
al., 1996b; Joseph et al., 1999). The importance
of this CSF-1-responsive bone marrow cell popu-
lation in osteoclast function and bone resorption
remains to be determined. However, enhanced
expression of GHr (Zhang et al., 1992; Symons
et al., 1996a, 1998; Tengku et al., 2000; Ong et
al., 2001), IGF-I (Symons et al., 1996a, 1998),
and IGF-Ir (Joseph et al., 1994; Ong et al.,
2001) by osteoclasts, on the adjacent alveolar
bone, has been observed during tooth eruption
and orthodontic tooth movement. Additionally,
in vitro studies have implicated a role for GH and
IGF-I in osteoclast maturation and bone resorp-
tion activity (Fiorelli et al., 1996; Chihara and
Sugimoto, 1997; Guicheux et al., 1998; Kanatani
et al., 2000).
At 14 days-of-age, the lower first molar in
normal rats is in the eruptive phase, with bone
resorption occurring above the erupting tooth to
provide an eruption pathway for emergence into
the oral cavity. The aim of this study was to take
advantage of this predictable, rapid recruitment of
osteoclasts, to determine the distribution of TRAP,
GHr, and IGF-I in osteoclast-like cells located on
alveolar bone margins, adjacent to the lower first
molar, in 14-day-old normal and mutant tl/tl rats
following treatment with CSF-1.
II. MATERIALS AND METHODS
A. Source and Treatment of Animals
Rats were bred and treated at the University of
Massachusetts Medical School. Osteopetrotic mu-
tant animals (tl/tl) were identified radiographically
at birth by the failure to develop marrow cavities in
long bones (Schneider et al., 1979). Normal ho-
mozygotes (+/+) and heterozygotes (+/tl) are distin-
guishable only by breeding, and normal littermates
included both these genotypes. Animals were main-
tained and used in accordance with directives of the
Guide for the Care and Use of Laboratory Animals,
prepared by the Animal Research Committee of
the University of Massachusetts Medical School
and guidelines from the Institute on Laboratory
Animals Resources, National Research Council
(DHHS Publ. NIH 86–23, 1985). Four normal
and four mutant rats were treated with highly
purified recombinant human CSF-1 (Ladner et al.,
1987; Halenbeck et al., 1989), which was gener-
ously provided by Chiron Corporation. Adminis-
tration of the growth factor was by subcutaneous
injection of 106 units every 48 hours (Ralph et al.,
1986), beginning at birth for a period of 2 weeks.
Four untreated mutants and four normal litter-
mates served as controls.
B. Tissue Preparation
At 14 days-of-age, animals were anesthetized
(Nembutal, 35 mg/kg), radiographed, and killed
by decapitation. The mandibles were removed,
fixed for 4 hours at 4°C in Bouin’s solution (1.2%
picric acid, 10% formaldehyde, and 5% glacial
acetic acid), washed twice in 10% EDTA for 30
minutes, demineralized for 14 days in 10% EDTA
at 4°C with two changes, dehydrated in alcohol, and
embedded in paraffin under vacuum using standard
methods. Transverse sections (5 µm thick) of the
lower first molar were mounted on glass slides.
C. Tartrate-Resistant Acid
Phosphatase Activity
Tartrate-resistant acid phosphatase (TRAP) ac-
tivity was demonstrated using napthol ASTR-
phosphate (in N,N-dimethyl formamide) as a
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substrate and pararosaniline-HCL as a coupling
agent in L(+)-tartric acid, at 37°C for 30 minutes
(Minkin, 1982). Slides were counterstained with
0.2% methyl green solution and mounted. Incuba-
tion with no substrate served as a control (Joseph et
al., 1999; Ong et al., 2000; Tengku et al., 2000).
D. Antibody Production
The following antibodies were used:
1. A monoclonal antibody to GHr raised in mice
against a human GH affinity purified rat liver
GHr (Barnard et al., 1984; 1985). This anti-
body has been used to detect the receptor in
rat tissue (Lobie et al., 1990; García-Aragón
et al., 1992; Zhang et al., 1992; Symons et al.,
1994, 1996a, 1996b, 1998; Tengku 2000;
Ong et al., 2001).
2. A polyclonal antibody to IGF-I was raised in
rabbit against recombinant human IGF-I.
This antibody has been shown to cross-react
with rat tissues and has been demonstrated to
have less than 0.5% cross-reactivity with
IGF-II (Breier et al., 1991; Joseph et al.,
1993, 1999; Ong et al., 2001).
E. Immunohistochemistry
Deparaffinized sections were processed for the
detection of GHr and IGF-I using a three-layer
streptavidin peroxidase technique. Specific tech-
niques for detection of GHr (Symons et al., 1994,
1996b, 1998; Zhang et al., 1992) and IGF-I
(Joseph et al., 1993, 1999) in rat tissue have previ-
ously been described. Sections were counterstained
with Mayer’s haematoxylin, dehydrated, mounted,
and viewed using a light microscope magnification
of 100×. Controls included: (a) omission of the
primary antibody; (b) omission of the secondary
antiserum; (c) incubation with nonimmune serum;
(d) use of rat liver tissue (GHr) and digestive tract
(IGF-I) as a positive control.
F. Quantitation of TRAP and Antibody
Expression by Osteoclast-like Cells
Multinuclear osteoclast-like cells positive for
TRAP, GHr, and IGF-I on the adjacent bone
surface surrounding the molar crown were counted
at a magnification of 100×. The total number of
positive cells was determined and then expressed
as the number of positive cells per unit (linear
millimeter) of bone surface. The adjacent bone
surface was that surface that faced the buccal,
occlusal, and lingual aspects of the molar crown
and did not include bone surfaces adjacent to
developing roots. The length of the adjacent
bone margin was determined from photographic
records of each section. The adjacent bone mar-
gin surface was outlined and a linear measure-
ment (mm) determined. Two sections per animal,
per group were used for cell counts, providing 8
sections per stain for each analysis. Arithmetic
means and standard deviations were determined
for each group. The comparative differences in
mean values were tested using a one-way analy-
sis of variance (ANOVA) program (InStat,
GraphPad Software Inc., San Diego, CA, USA).
Differences were considered significant at the
p < 0.05 level.
III. RESULTS
A. Specificity of
Immunohistochemical Staining
TRAP activity was not detected in sections where
the substrate was omitted. Immunoreactivity was
not observed in sections incubated without pri-
mary antibody, without the secondary antiserum,
and with nonimmune serum. Immunoreactivity
was observed only in sections incubated with the
test antibodies. Antibody reaction was confirmed
by using appropriate tissue sections from the rat,
which demonstrate immunoreactivity for the test
antibody (Symons et al., 1996a, 1996b, 1998;
Joseph et al., 1999).
B. Relationship of the Adjacent Bone to
the Occlusal Surface of the First
Mandibular Molar
Resorption of bone occlusal to the erupting molar
was evident in normal and CSF-1–treated normal
rats. In these animals, at 14 days-of-age, no
morphological differences were observed in the
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development of the first molar and its relationship
to the adjacent alveolar bone. Alveolar bone was
present on the buccal and lingual aspects, and the
molar was close to emerging into the oral cavity.
In tl/tl rats, lack of bone resorption prevented
expansion of the crypt around the first molar.
Alveolar bone adjacent to the developing crown
was present on the buccal and lingual, and ex-
tended over the lateral aspects of the occlusal
surface covering approximately half the occlusal
surface. In tl/tl rats treated with CSF-1, bone
was present only on the buccal and lingual as-
pects of the first molar.
C. TRAP Activity and Antibody
Immunoreactivity
TRAP-positive staining was located in the cyto-
plasm of osteoclast-like cells in all groups. Osteo-
clast-like cells in the tl/tl rat tended to be smaller
and stained less intensely for TRAP activity (Fig. 1).
Total cell counts for TRAP activity and immuno-
reactivity are presented in Table 1. CSF-1 treat-
ment significantly increased the number of
TRAP-positive osteoclast-like cells in the tl/tl rat
(p < 0.001). No such effect was observed for
normal animals.
FIGURE 1. Sections of bone (B) adjacent to the molar crown showing TRAP activity of osteoclast-like cells
(arrowed) from (a) normal; (b) tl/tl; (c) normal CSF-1–treated, and (d) tl/tl CSF-1–treated rats. Bar = 50 µm.
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In all groups studied, many osteoclast-like cells
lacked GHr immunoreactivity. GHr-negative
osteoclast-like cells tended to be ovoid to columnar
in shape and had a smaller zone of contact with
bone (Fig. 2A). In tl/tl tissue sections, osteoclast-
like cells tended to be negative for GHr immuno-
reactivity. Only the occasional osteoclast-like cell
demonstrated very faint staining on the cell mem-
brane adjacent to the bone (Fig. 2B). In normal
and both CSF-1–treated groups, GHr immuno-
reactivity was observed occasionally in both the
cytoplasm and nucleus (Fig. 2C), on the cell
membrane (Fig. 2D), and more commonly in the
cytoplasm (Fig. 2E).
IGF-I immunoreactivity was present in a small
number of osteoclast-like cells in all animal groups
examined. Immunoreactivity was observed in the
cytoplasm (Fig. 2F) and in both the cytoplasm and
nuclei (Fig. 2G).
There was no significant difference in the
total number of TRAP-, GHr-, and IGF-I–posi-
tive osteoclast-like cells on the adjacent bone
margin for normal and normal CSF-1–treated
animals. CSF-1 treatment significantly increased
the total number of TRAP- (p < 0.001), GHr-
(p < 0.05), and IGF-I-positive (p < 0.01) osteo-
clast-like cells in tl/tl animals. Overall relatively
few osteoclast-like cells expressed GHr and IGF-I.
Cells immunoreactive to GHr were not necessar-
ily immunoreactive to IGF-I.
The length of the bone margin adjacent to the
developing crown was determined by resorption
forming the eruption pathway and expansion of
the crypt to accommodate the developing molar
(Table 2). CSF-1 treatment did not significantly
alter the length of the adjacent bone margin in the
normal or tl/tl group. Treatment with CSF-1
significantly increased the number of TRAP-
(p < 0.001), and GHr-positive (p < 0.05) osteo-
clast-like cells per linear mm in the tl/tl rat. No
significant difference in the number of IGF-I–
positive osteoclast-like cells/mm bone was ob-
served (Table 2).
IV. DISCUSSION
We used tooth eruption as a model (Marks and
Cahill, 1987) to examine the immunoreactivity of
osteoclast-like cells to GHr and IGF-I following
treatment with exogenous CSF-1. In the normal
animal, CSF-1 treatment did not affect the num-
ber of positive osteoclast-like cells for TRAP, GHr
and IGF-I. CSF-1 treatment significantly increased
the number of TRAP- (p < 0.001), GHr- (p < 0.05),
and IGF-I–positive (p < 0.01) osteoclast-like cells
in the tl/tl rat.
Where the bone resorption necessary for tooth
eruption occurred in normal rats, a small percent-
age of the osteoclast-like cell population demon-
strated immunoreactivity to GHr. Variations were
noted in the distribution of this immunoreactivity
within these cells. Generally, tl/tl rat osteoclast-
like cells lacked immunoreactivity for GHr. How-
ever, at high magnification, pale staining was
observed in the region of the cell approximating
the bone surface. Following CSF-1 treatment,
osteoclast-like cells in tl/tl tissue sections demon-
TABLE 1
Total Number of TRAP-, GHr-, and IGF-I–Positive
Osteoclast-like Cells (Mean ± SD) on the Bone Margin
Adjacent to the Lower First Molar Crown
Group N TRAP GHr IGF-I
Normal 4   4.0 ± 0.8 0.3 ± 0.3 1.8 ± 1.7
tl/tl 4   3.6 ± 0.7 0.1 ± 0.0 0.8 ± 0.5
Normal + CSF-1 4   4.1 ± 1.1 0.4 ± 0.4 2.0 ± 1.8
tl/tl + CSF-1 4 18.4 ± 4.3*** 3.4 ± 2.6* 5.5 ± 1.9**
*p < 0.05; **p < 0.01; ***p < 0.001.
Note: CSF-1 significantly increased total positive cell count in the
tl/tl rat.
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FIGURE 2. Sections showing immunoreactivity for GHr (a–e) and IGF-I (f–g) in osteoclast-like cells from (a) normal
animal showing no reactivity; (b) tl/tl animal, faint immunoreactivity (arrowed) in the cytoplasm adjacent to bone;
(c) normal CSF-1–treated animal, reactivity in the cytoplasm and nuclei; (d) tl/tl CSF-1–treated animal, reactivity on
the cell membrane; (e) tl/tl CSF-1–treated animal, reactivity in the cytoplasm; (f) tl/tl CSF-1–treated animal, reactivity
in the cytoplasm, and (g) tl/tl CSF-1–treated animal, reactivity in the nuclei. Bone (B). Bar = 25 µm.
strated a more intense GHr immunoreactivity in
the cytoplasm and occasionally in the nucleus. A
positive reaction on the cell membrane was only
visible in cells with little or no staining within the
cytoplasm and may imply the presence of receptors
at this site. IGF-I immunoreactivity was observed
in a greater proportion of osteoclast-like cells in all
groups studied. Distribution of IGF-I immuno-
reactivity within the cells was variable but tended to
be located in the cytoplasm and occasionally in the
nucleus. The cellular morphology of osteoclast-like
cells that demonstrated GHr and IGF-I immuno-
reactivity was similar to that of osteoclasts active
in bone resorption.
CSF-1 treatment significantly increased the
number of TRAP-positive osteoclast-like cells on
the adjacent bone margin in the tl/tl rat. Cell
counts for TRAP-positive osteoclast-like cells in
the experimental groups studied are similar to that
previously reported (Cielinski et al., 1995). In the
CSF-1–treated tl/tl rat, intense TRAP activity
was present on the buccal and lingual bone mar-
gins, in particular, on those margins closest to the
oral cavity. As previously reported, reduced TRAP
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staining was observed in tl/tl tissue sections
(Cielinski et al., 1995).
Bone resorption activity associated with the
lower first molar in the tl/tl rat was consistent with
that previously reported (Iizuka et al., 1992; Cielinski
et al., 1995). In the tl/tl rat, the molar crown was
almost completely surrounded by bone (Iizuka et al.,
1992) and little space was present between the bone
and developing molar. However, following CSF-1
treatment in the tl/tl rat, expansion of the crypt
permitted the molar crown development to progress
normally and bone resorption forming an eruption
pathway was evident.
GH is a major regulator of postnatal skeletal
growth and development (Underwood and Van
Wyk, 1992) and regulates growth either directly
or through the actions of the mediator IGF-I
(Salmon and Daughaday, 1957). In vivo admin-
istration of hGH leads to an activation of osteo-
clasts and osteoblasts (Vandeweghe et al., 1993;
Kassem et al., 1994; Brixen et al., 1995). It is
possible that GH affects osteoclastic bone resorp-
tion by directly acting on mature osteoclasts and
their precursor cells or by indirectly acting on
them via nonosteoclastic cells, such as stromal
cells (including osteoblasts) (Nishiyama et al.,
1996; Guicheux et al., 1998). The mechanism of
action of GH on bone resorption mediated by
stromal cells may be through an increase in
IGF-I production and/or activity (Nishiyama et
al., 1996; Rousselle et al., 2000).
The expression of GHr by osteoclast-like cells
during tooth eruption and tooth movement (Zhang
et al., 1992; Symons et al., 1996a, 1998; Tengku
et al., 2000; Ong et al., 2001) suggests a role for
GH in local alveolar bone resorption necessary for
tooth eruption. The present study supports the
above proposal, since GHr immunoreactivity was
located on the cell membrane in the cytoplasm
and nuclear region of osteoclast-like cells whose
morphology resembled that of a functioning osteo-
clast. The variation in location of the GHr immu-
noreactivity may reflect the processing of the GHr
molecule by the individual cell. The almost com-
plete absence of GHr expression in tl/tl osteoclast-
like cells may be due to a deficiency in suitable
osteoclast precursors, as bone marrow spaces are
restricted in these animals and contain few mono-
nuclear cells, and those mononuclear cells that are
present lack GHr immunoreactivity (Symons et
al., 1996b). CSF-1 ameliorates the osteopetrotic
condition and upregulates the expression of GHr
(Symons et al., 1996b), IGF-I (Joseph et al.,
1999) and IGF-Ir (Joseph et al., 1999), in bone
marrow cells in the tl/tl rat. The role of these
mononuclear cells in osteoclast formation and
function remains to be determined. However, GH
is able to stimulate mouse osteoclast-like cell
formation from hemopoietic blast cells supported
by GM-CSF (Nishiyama et al., 1996). The PCR
product of mouse GHr was detected in these
hemopoietic blast cells supported by GM-CSF,
indicating a possible mechanism whereby GH
may interact with osteoclast precursors and stimu-
late osteoclast-like cell formation (Nishiyama et
al., 1996; Chihara and Sugimoto, 1997).
TABLE 2
Length of Bone Margin Surrounding the Lower First Molar Crown
(mm) and the Number (Mean ± SD) of Positive Osteoclast-like Cells/
mm Bone Margin
Group N Bone margin (mm) TRAP GHr IGF-I
Normal 4 1.17 ± 0.16 3.4 ± 0.6 0.2 ± 0.2 1.5 ± 1.5
tl/tl 4 1.85 ± 0.56 1.9 ± 0.4 0.1 ± 0.0 0.4 ± 0.3
Normal + CSF-1 4 0.98 ± 0.14 4.2 ± 1.1 0.4 ± 0.4 2.0 ± 1.8
tl/tl + CSF-1 4 2.11 ± 0.3 8.7 ± 2.0*** 1.6 ± 1.2* 2.6 ± 0.9
* p < 0.05; *** p < 0.001.
Note: CSF-1 significantly increased the number of TRAP- and GHr-positive cells/
mm bone in the tl/tl rat.
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The expression of IGFs has been demon-
strated in preosteoclasts (Fiorelli et al., 1996) and
osteoclasts (Middleton et al., 1995). Similarly, in
the present study, IGF-I was expressed in osteo-
clast-like cells and was located in the cytoplasm
and within the nuclear region. Expression of IGF-I,
but very limited GHr, by osteoclast-like cells in
the tl/tl mutant, is interesting and suggests that
local IGF-I production may be partially indepen-
dent of GH. This is supported by the observation
that the bone resorption, necessary for tooth erup-
tion, proceeds normally in GH-deficient rodents
(Symons and Seymour, 2000). The presence of a
functionally active specific IGF-Ir on mature os-
teoclasts supports a role for IGF-I in the activation
of mature osteoclasts through the direct stimulation
of local transmembrane receptors (Hou et al., 1997;
Middleton et al., 1995). A binding site for IGF-I
has been reported on hematopoietic blast cells
(Nishiyama et al., 1996), which implies that IGF-I
may directly stimulate the recruitment and forma-
tion of osteoclasts. It has been shown that IGF-I
supports the activation and formation of osteoclasts
and that osteoblasts mediate IGF-I–stimulated
formation of osteoclasts (Slootweg et al., 1992;
Mochizuki et al., 1992; Hill et al., 1995).
This study has shown that a number of osteo-
clast-like cells located in an area where bone resorp-
tion occurs during the formation of an eruption
pathway are immunoreactive for GHr and IGF-I.
Treatment of the tl/tl rat with CSF-1 increased the
number of TRAP-, GHr-, and IGF-I–positive
osteoclast-like cells on the bone margin adjacent to
the crown of the lower first molar concomitant with
the restoration of bone resorption. These data
support the postulate that in the tl/tl rat, CSF-1 is
involved in the stimulation of bone resorption and
development of functional osteoclast-like cells that
may be immunoreative for GHr and IGF-I. How-
ever, as CSF-1 only partially resolves the bone
resorption defect in the tl/tl rat (Marks et al.,
1993; Sundquist et al., 1995), other growth factors
may be required to normalize osteoclast number
and activity.
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